TrialBMJ open2014

Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial.

Sine Schnoor Buhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.